Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Wednesday 04 November, 2020

Benchmark Hlgs PLC

Investor Presentation for Retail Investors

RNS Number : 1575E
Benchmark Holdings PLC
04 November 2020

Benchmark Holdings plc


("Benchmark" or the "Company")


Equity Development Final Results Investor Presentation for Retail Investors


Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will be conducting a presentation covering its Final Results for the year ended 30th September 2020 for retail investors and wealth managers. The presentation will be hosted online by Trond Williksen, Chief Executive Officer, and Septima Maguire, Chief Financial Officer.

The event will take place at 12.00pm UK time on Friday 27th November 2020.

The online presentation is primarily targeted at retail investors and wealth managers, and is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.


To register for the presentation, please visit:  Benchmark Holdings Final Results Presentation and Q&A.


A recording of the presentation will be available after the event at .


As per the Company's RNS announcement on 27 October 2020, a separate presentation for analysts will be held at 8:30am on 27 November 2020. To register your interest for that presentation please contact [email protected]




Equity Development 

Hannah Crowe


 Tel:  020 7065 2692 [email protected]


Benchmark Holdings plc

Tel:  020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

MHP Communications

Tel:  020 3128 8990

Katie Hunt, Reg Hoare, Alistair de Kare-Silver, Charlie Protheroe

[email protected]



This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t